David J. Anderson
Pacific Northwest National Laboratory
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by David J. Anderson.
Proceedings of the National Academy of Sciences of the United States of America | 2002
Mary S. Lipton; Ljiljana Pǎá-Toli; Gordon A. Anderson; David J. Anderson; Deanna L. Auberry; John R. Battista; Michael J. Daly; Jim K. Fredrickson; Kim K. Hixson; Heather M. Kostandarithes; Christophe D. Masselon; Lye Meng Markillie; Ronald J. Moore; Margaret F. Romine; Yufeng Shen; Eric Stritmatter; Nikola Tolić; Harold R. Udseth; Amudhan Venkateswaran; Kwong Kwok Wong; Rui Zhao; Richard D. Smith
Understanding biological systems and the roles of their constituents is facilitated by the ability to make quantitative, sensitive, and comprehensive measurements of how their proteome changes, e.g., in response to environmental perturbations. To this end, we have developed a high-throughput methodology to characterize an organisms dynamic proteome based on the combination of global enzymatic digestion, high-resolution liquid chromatographic separations, and analysis by Fourier transform ion cyclotron resonance mass spectrometry. The peptides produced serve as accurate mass tags for the proteins and have been used to identify with high confidence >61% of the predicted proteome for the ionizing radiation-resistant bacterium Deinococcus radiodurans. This fraction represents the broadest proteome coverage for any organism to date and includes 715 proteins previously annotated as either hypothetical or conserved hypothetical.
Molecular & Cellular Proteomics | 2005
Wei Jun Qian; Matthew E. Monroe; Tao Liu; Jon M. Jacobs; Gordon A. Anderson; Yufeng Shen; Ronald J. Moore; David J. Anderson; Rui Zhang; Steve E. Calvano; Stephen F. Lowry; Wenzhong Xiao; Lyle L. Moldawer; Ronald W. Davis; Ronald G. Tompkins; David G. Camp; Richard D. Smith; Henry V. Baker; Paul E. Bankey; Timothy R. Billiar; Bernard H. Brownstein; Irshad H. Chaudry; J. Perren Cobb; Adrian Fay; Robert J. Feezor; Brad Freeman; Richard L. Gamelli; Nicole S. Gibran; Brian G. Harbrecht; Doug Hayden
Identification of novel diagnostic or therapeutic biomarkers from human blood plasma would benefit significantly from quantitative measurements of the proteome constituents over a range of physiological conditions. Herein we describe an initial demonstration of proteome-wide quantitative analysis of human plasma. The approach utilizes postdigestion trypsin-catalyzed 16O/18O peptide labeling, two-dimensional LC-FTICR mass spectrometry, and the accurate mass and time (AMT) tag strategy to identify and quantify peptides/proteins from complex samples. A peptide accurate mass and LC elution time AMT tag data base was initially generated using MS/MS following extensive multidimensional LC separations to provide the basis for subsequent peptide identifications. The AMT tag data base contains >8,000 putative identified peptides, providing 938 confident plasma protein identifications. The quantitative approach was applied without depletion of high abundance proteins for comparative analyses of plasma samples from an individual prior to and 9 h after lipopolysaccharide (LPS) administration. Accurate quantification of changes in protein abundance was demonstrated by both 1:1 labeling of control plasma and the comparison between the plasma samples following LPS administration. A total of 429 distinct plasma proteins were quantified from the comparative analyses, and the protein abundances for 25 proteins, including several known inflammatory response mediators, were observed to change significantly following LPS administration.
Proceedings of the National Academy of Sciences of the United States of America | 2008
Olivier Pertz; Yingchun Wang; Feng Yang; Wei Wang; Marina A. Gristenko; Therese R. Clauss; David J. Anderson; Tao Liu; Kenneth J. Auberry; David G. Camp; Richard D. Smith; Richard L. Klemke
Neurite extension and growth cone navigation are guided by extracellular cues that control cytoskeletal rearrangements. However, understanding the complex signaling mechanisms that mediate neuritogenesis has been limited by the inability to biochemically separate the neurite and soma for spatial proteomic and bioinformatic analyses. Here, we apply global proteome profiling in combination with a neurite purification methodology for comparative analysis of the soma and neurite proteomes of neuroblastoma cells. The spatial relationship of 4,855 proteins were mapped, revealing networks of signaling proteins that control integrins, the actin cytoskeleton, and axonal guidance in the extending neurite. Bioinformatics and functional analyses revealed a spatially compartmentalized Rac/Cdc42 signaling network that operates in conjunction with multiple guanine-nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) to control neurite formation. Interestingly, RNA interference experiments revealed that the different GEFs and GAPs regulate specialized functions during neurite formation, including neurite growth and retraction kinetics, cytoskeletal organization, and cell polarity. Our findings provide insight into the spatial organization of signaling networks that enable neuritogenesis and provide a comprehensive system-wide profile of proteins that mediate this process, including those that control Rac and Cdc42 signaling.
Journal of Proteome Research | 2012
Alexandra C. Schrimpe-Rutledge; Ghislaine Fontés; Marina A. Gritsenko; Angela D. Norbeck; David J. Anderson; Katrina M. Waters; Joshua N. Adkins; Richard D. Smith; Vincent Poitout; Thomas O. Metz
The prevalence of diabetes mellitus is increasing dramatically throughout the world, and the disease has become a major public health issue. The most common form of the disease, type 2 diabetes, is characterized by insulin resistance and insufficient insulin production from the pancreatic beta-cell. Since glucose is the most potent regulator of beta-cell function under physiological conditions, identification of the insulin secretory defect underlying type 2 diabetes requires a better understanding of glucose regulation of human beta-cell function. To this aim, a bottom-up LC-MS/MS-based proteomics approach was used to profile pooled islets from multiple donors under basal (5 mM) or high (15 mM) glucose conditions. Our analysis discovered 256 differentially abundant proteins (∼p < 0.05) after 24 h of high glucose exposure from more than 4500 identified in total. Several novel glucose-regulated proteins were elevated under high glucose conditions, including regulators of mRNA splicing (pleiotropic regulator 1), processing (retinoblastoma binding protein 6), and function (nuclear RNA export factor 1), in addition to neuron navigator 1 and plasminogen activator inhibitor 1. Proteins whose abundances markedly decreased during incubation at 15 mM glucose included Bax inhibitor 1 and synaptotagmin-17. Up-regulation of dicer 1 and SLC27A2 and down-regulation of phospholipase Cβ4 were confirmed by Western blots. Many proteins found to be differentially abundant after high glucose stimulation are annotated as uncharacterized or hypothetical. These findings expand our knowledge of glucose regulation of the human islet proteome and suggest many hitherto unknown responses to glucose that require additional studies to explore novel functional roles.
Analytical Chemistry | 2001
Thomas P. Conrads; Kim Alving; Timothy D. Veenstra; Mikhail E. Belov; Gordon A. Anderson; David J. Anderson; Mary S. Lipton; Lijliana Pasa-Tolic; Harold R. Udseth; William B. Chrisler; Brian D. Thrall; Richard D. Smith
Journal of Proteome Research | 2005
Haixing H. Wang; Wei Jun Qian; Heather M. Mottaz; Therese R. Clauss; David J. Anderson; Ronald J. Moore; David G. Camp; Arshad H. Khan; Daniel M. Sforza; Maria G. Pallavicini; Desmond J. Smith; Richard D. Smith
Journal of Proteome Research | 2004
Jon M. Jacobs; Heather M. Mottaz; Li Rong Yu; David J. Anderson; Ronald J. Moore; Wan Nan U Chen; Kenneth J. Auberry; Eric F. Strittmatter; Matthew E. Monroe; Brian D. Thrall; David G. Camp; Richard D. Smith
Analytical Chemistry | 2002
Lian Shan; David J. Anderson
Proteomics | 2005
Tao Liu; Wei Jun Qian; Wan Nan U Chen; Jon M. Jacobs; Ronald J. Moore; David J. Anderson; Marina A. Gritsenko; Matthew E. Monroe; Brian D. Thrall; David G. Camp; Richard D. Smith
Genome Research | 2007
Vladislav A. Petyuk; Wei Jun Qian; Mark H. Chin; Haixing H. Wang; Eric A. Livesay; Matthew E. Monroe; Joshua N. Adkins; Navdeep Jaitly; David J. Anderson; David G. Camp; Desmond J. Smith; Richard D. Smith